Newsletter Subscribe

Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Prevent Blindness Offers GA Educational Materials

Prevent Blindness, a leading nonprofit organization dedicated to eye health, has announced its fourth annual Geographic Atrophy (GA) Awareness Week, taking place from December 2–8, 2024. Geographic Atrophy, an advanced form of dry age-related macular degeneration (AMD), affects an estimated…

AI-Ready Dataset Released for Type 2 Diabetes Research

A groundbreaking study has unveiled a flagship dataset designed to explore the biomarkers and environmental influences that contribute to the development of type 2 diabetes (T2D). This comprehensive dataset includes data from participants ranging from healthy individuals to those at…

ONS-5010 Falls Short in NORSE EIGHT Trial for Wet AMD

ONS-5010 (LYTENAVA), an ophthalmic formulation of bevacizumab for treating wet age-related macular degeneration (AMD), failed to meet the noninferiority endpoint in the NORSE EIGHT clinical trial, according to preliminary topline results announced by Outlook Therapeutics. About the NORSE EIGHT Trial…

Gene Editing Offers Hope for Retinitis Pigmentosa

Researchers funded by the National Eye Institute (NEI) have made significant strides in the treatment of retinitis pigmentosa (RP), a genetic disorder that causes progressive vision loss. Using a CRISPR-Cas9-based tool called base editing, the team corrected a specific mutation…

ImprimisRx Wins $34.9M Trademark Case Against OSRX

In a landmark decision, a California jury unanimously ruled in favor of ImprimisRx in its trademark infringement lawsuit against OSRX and its related entity Ocular Science, according to a press release. The jury awarded ImprimisRx a total of $34.9 million…

AOAExcel Endorses Barti Software as First Eye Care EHR

AOAExcel, a for-profit subsidiary and member-benefit arm of the American Optometric Association (AOA), has announced its first-ever endorsement of an Electronic Health Records (EHR) system—Barti Software. This partnership includes a financial investment in the San Francisco-based EHR provider, marking a…

J&J Names Shawn Millerick Vision Care President

Johnson & Johnson has announced the appointment of Shawn Millerick as the new President of Vision Care, Americas, effective November 11, 2024. In his new role, Mr. Millerick will oversee the strategy and growth of Johnson & Johnson’s Vision Care…

Avirmax Launches ABI-110 Gene Therapy Trial for Wet AMD

Avirmax Biopharma has reached a major milestone in its mission to revolutionize the treatment of wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) by successfully dosing the first patient in the phase I/IIa clinical trial of ABI-110, the…

Stay informed and not overwhelmed, subscribe now!